| Document Date: 2012-08-16 01:05:06
Open Document File Size: 1,48 MBShare Result on Facebook
Company D 68 32 Group 14 3 14 Group / D 54 32 4 4 7 Group / Methodology / A B C D Group / C 75 25 D 68 32 Group / / IndustryTerm acute in-scope services / medication audit / / MedicalCondition Mental retardation / Schizophrenia / hallucinations / injury / Mood disorder / Mood Disorders / schizotypal and delusional disorders / disorders / / MedicalTreatment polypharmacy / / Organization Queensland Mental Health Benchmarking Unit / Centre for Mental Health / Australian Council of Health Care Standards / / / Position interpreter / / Product Venlafaxine / Diazepam / Haloperidol Decanoate / Mirtazapine / Olanzapine / Fluoxetine / Clozapine / Haloperidol / Escitalopram / Forensic Forum Seclusion Medication / National Mental Health Benchmarking Project Forensic Forum Special Project Seclusion Medication / Lorazepam / Temazepam / Risperidone / Clonazepam / F20-29 Schizophrenia / Fluphenazine Decanoate / BZ medication / Valium / /
SocialTag |
National Mental Health Benchmarking Project